Consolidated Statement Of Cash Flows

EnBio Holdings,Inc - Filing #7248671

Concept As at
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2023-03-31
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
291,610,000 JPY
2,067,467,000 JPY
Interest and dividends received
16,214,000 JPY
30,994,000 JPY
Interest paid
-141,156,000 JPY
-115,599,000 JPY
Net cash provided by (used in) operating activities
21,919,000 JPY
1,663,431,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-1,462,028,000 JPY
-1,079,075,000 JPY
Purchase of investment securities
-3,312,000 JPY
-1,888,000 JPY
Net cash provided by (used in) investing activities
-1,602,974,000 JPY
-1,583,696,000 JPY
Loan advances
-121,811,000 JPY
-280,085,000 JPY
Other, net
1,661,000 JPY
-27,858,000 JPY
Cash flows from financing activities
Proceeds from issuance of shares
JPY
1,056,000,000 JPY
Purchase of treasury shares
-34,987,000 JPY
JPY
Dividends paid
-65,013,000 JPY
-52,965,000 JPY
Proceeds from long-term borrowings
2,529,391,000 JPY
1,987,400,000 JPY
Repayments of long-term borrowings
-1,906,749,000 JPY
-2,498,317,000 JPY
Redemption of bonds
JPY
-36,500,000 JPY
Purchase of shares of subsidiaries not resulting in change in scope of consolidation
JPY
-1,500,000 JPY
Net cash provided by (used in) financing activities
1,274,028,000 JPY
638,922,000 JPY
Effect of exchange rate change on cash and cash equivalents
-4,486,000 JPY
7,821,000 JPY
Net increase (decrease) in cash and cash equivalents
-311,513,000 JPY
726,478,000 JPY
Cash and cash equivalents
3,263,030,000 JPY
3,574,064,000 JPY
2,798,635,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.